LifeVantage Corporation (OTCBB: LFVN), http://www.lifevantage.com, maker of Protandim(R), today announced results for its second quarter ended December 31, 2007. For the three month period ended December 31, 2007, the Company recorded net revenues of $0.8 million and a loss of $(0.4) million, or $(0.02) per share. For the three month period ended December 31, 2006, the Company recorded net revenues of $1.1 million and a loss of $(1.8) million, or $(0.08) per share.

For the six month period ended December 31, 2007, the Company recorded net revenues of $1.6 million and a loss of $(0.7) million, or $(0.03) per share comparing to net revenues of $3.2 million and a loss of $(2.6) million, or $(0.12) per share for the six month period ended December 31, 2006.